IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Sectoral Asset Management Inc

Q3 2018 Holdings

Filed 2018-11-14 | 168 holdings | $108.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
LA Jolla Pharmaceutical(LJPC)COM503459604$33.2K1,648,7720.0%
Apellis Pharmaceuticaks(APLS)COM03753U106$36.2K2,038,5160.0%
Aerie Pharmaceuticals(AERIEUR)COM00771V108$47.9K777,4700.0%
Amicus Therapeutics(FOLD)COM03152W109$58.8K4,867,2900.1%
Corvus Pharmaceuticals(CRVS)COM221015100$108.0K12,5940.1%
Cytokinetics Inc(CYTK)COM23282W605$153.0K15,5820.1%
Cytomx Therapeutics(CTMX)COM23284F105$186.0K10,0580.2%
Amneal Pharmaceuticals(AMRX)COM03168L105$201.0K9,0400.2%
Cerus Corp(CERS)COM157085101$437.0K60,5760.4%
Coherus Biosciences(CHRS)COM19249H103$462.0K27,9870.4%
Biogen Inc(BIIB)COM09062X103$587.0K1,6620.5%
Beigene Limited(ONC)SP ADR07725L102$1.7M9,9271.6%
Agios Pharmaceutics(AGIO)COM00847X104$4.3M56,2074.0%
Atricure Inc(ATRC)COM04963C209$8.8M250,8248.1%
Boston Scientific(BSX)COM101137107$9.7M251,3768.9%
Biomarin Pharmaceutical(BMRN)COM09061G101$17.9M184,69516.5%
Collegium Pharmaceutical(COLL)COM19459J104$29.3M1,989,45527.1%
Alnylam Pharmaceuticals(ALNY)COM02043Q107$33.6M384,04131.0%
PreviousPage 4 of 4